Specific inhibitory effects of guanosine on breast cancer cell proliferation

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Breast cancer is a leading cause of death, with current treatments being cytotoxic.
• Intracellular guanosine triphosphate (GTP) levels are elevated in proliferating cancer cells, presenting a potential therapeutic target.
• Targeting GTP metabolism offers a promising avenue for developing novel breast cancer therapies.

Purpose of the Study:

• To investigate the role of intracellular guanosine triphosphate (GTP) in breast cancer cell proliferation.
• To examine the effects of mycophenolic acid (MPA) and Guanosine (Guo) on GTP levels and cell proliferation in normal and cancer breast cell lines.
• To explore the potential of Guanosine (Guo) as a targeted therapy for breast cancer.

Main Methods:

• Utilized normal (MCF-12A) and cancer (MCF-7) breast cell lines.
• Administered mycophenolic acid (MPA), an inosine monophosphate dehydrogenase inhibitor, to reduce intracellular GTP levels.
• Assessed the impact of MPA, Guanosine (Guo), and their combination on cell proliferation and intracellular GTP/ATP levels.

Main Results:

• MPA significantly decreased cell proliferation in both normal and cancer breast cell lines by reducing intracellular GTP levels.
• Co-administration of Guanosine (Guo) with MPA reversed the inhibitory effects of MPA on cell proliferation.
• Single exposure to Guanosine (Guo) inhibited proliferation in MCF-7 (cancer) cells but not in MCF-12A (normal) cells.
• The antiproliferative effects of Guanosine (Guo) did not directly correlate with intracellular GTP or ATP levels or the GTP/ATP ratio.

Conclusions:

• MPA effectively reduces breast cancer cell proliferation by targeting GTP metabolism.
• Guanosine (Guo) exhibits selective antiproliferative effects on breast cancer cells, independent of direct GTP level modulation.
• Guanosine (Guo) warrants further investigation as a potential therapeutic agent for breast cancer treatment.